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Abstract
Background: Herpes simplex virus type-1 (HSV-1) infections can cause a number of diseases ranging from simple
cold sores to dangerous keratitis and lethal encephalitis. The interaction between virus and host cells, critical for
viral replication, is being extensively investigated by many laboratories. In this study, we tested the hypothesis that
HSV-1 lytic infection triggers the expression of important multi-functional transcription factor Egr1. The mechanisms
of induction are mediated, at least in part, by signaling pathways such as NFB and CREB.
Methods: SIRC, VERO, and 293HEK cell lines were infected with HSV-1, and the Egr-1 transcript and protein were
detected by RT-PCR and Western blot, respectively. The localization and expression profile of Egr-1 were
investigated further by immunofluorescence microscopy analyses. The recruitment of transcription factors to the
Egr-1 promoter during infection was studied by chromatin immunoprecipitation (ChIP). Various inhibitors and
dominant-negative mutant were used to assess the mechanisms of Egr-1 induction and their effects were
addressed by immunofluorescence microscopy.
Results: Western blot analyses showed that Egr-1 was absent in uninfected cells; however, the protein was
detected 24-72 hours post treatment, and the response was directly proportional to the titer of the virus used for
infection. Using recombinant HSV-1 expressing EGFP, Egr-1 was detected only in the infected cells. ChIP assays
demonstrated that NFкB and cAMP response element binding protein (CREB) were recruited to the Egr-1 promoter
upon infection. Additional studies showed that inhibitors of NFкB and dominant-negative CREB repressed the Egr-1
induction by HSV-1 infection.
Conclusion: Collectively, these results demonstrate that Egr-1 is expressed rapidly upon HSV-1 infection and that
this novel induction could be due to the NFкB/CREB-mediated transactivation. Egr-1 induction might play a key
role in the viral gene expression, replication, inflammation, and the disease progression.
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Background
Herpes simplex virus type-1 (HSV-1) is a common
pathogen with worldwide seroprevalence rates ranging
from 50% to 90% [1-3]. It is a neurotropic virus that is
in the subfamily of alpha herpesvirinae.I n i t i a lo rp r i -
mary infection with HSV-1 mostly occurs during child-
hood in mucoepithelial surfaces and is generally mild or
asymptomatic. Upon infection of epithelial cells, HSV-1
initiates lytic replication, and at the end of this cycle,
the virus infects sensory neurons proximal to the site of
primary infection. Virions can travel via retrograde axo-
nal transport to the cell bodies of neurons in the tri-
geminal ganglia where lifelong latency is established [4].
The latent virions can reactivate due to unknown causes
and prohibit subsequent lytic infections. The most com-
mon form of lytic infection is the cold sore or fever blis-
ter where viral replication takes place in the orofacial
mucosa [5]. Infection of the brain leads to herpes
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manent neurological damage with high mortality [5].
Orofacial infection, although less threatening, represents
the major route for transmission to a naive host.
In addition to encephalopathy and orofacial infection,
HSV-1 also infects the eyes leading to 8 cases of herpe-
tic keratitis per 100,000 population every year [6]. Kera-
titis refers to inflammation of corneal epithelium due to
a number of irritants such as infections by viruses, bac-
teria, and fungi. Herpetic keratitis is the major cause of
c o r n e a lb l i n d n e s s ,w i t hu n i l a t e r a lv i s u a li m p a i r m e n t
occurring in at least one-third of patients with recurrent
disease [7].
Lytic infections of HSV-1 are typically characterized
by the entry of virus into the cell and translocation of
the viral genome into the nucleus followed by replica-
tion and evasion of host defenses in order to disperse
and persist in the environment. Gene expression of
HSV-1 is tightly regulated in a cascade fashion. The
three temporal classes of genes are designated immedi-
ate-early (a), early (b)a n dl a t e( g) genes [8]. There are
five a genes, designated ICP0, ICP4, ICP22, ICP27, and
ICP47. The a genes were defined by the presence of the
cis element for induction by VP16, which interacts with
cellular factors, including the protein Oct-1, a homeo-
box protein, to activate viral immediate early (IE) gene
transcription in trans [9,10]. The expression of b genes
requires the expression of a genes, especially functional
ICP4. ICP0 enhances the ability of ICP4 to trans-activate
g genes [11]. The expression of g gene has been shown
to be blocked by effective concentrations of DNA synth-
esis inhibitors [12]. All of these steps require interaction
between viral and host components. The communica-
tion between virus and host factors is being investigated
by many laboratories but is not understood completely,
and identification of host factors that interact with the
virus remains a challenge. Additional information will
identify new drug targets for treatment and will aid in
understanding the complex processes of initiation of
HSV-1 latency and reactivation.
Our laboratory examined the hypothesis that HSV-1
infection of epithelial cells including a cell line from
rabbit cornea rapidly induced the expression of the cel-
lular transcription factor early growth response-1 (Egr-
1), also known as NGFI-a, Zif268, Krox24, TIS8, and
ZENK. The Early Growth Response (EGR) family
belongs to the C2H2-type zinc-finger proteins [13-15].
Egr-1 functions as a convergence point for many signal-
ing cascades and is known to play an important role in
regulating inflammation, cell proliferation, and apoptosis
[16]. Our previous transient cotransfection studies with
promoter plasmids and Egr-1 expression vector showed
that Egr-1 regulated HSV-1 ICP22 and ICP4 promoter
activity [17]. In the present study, we demonstrate for
the first time that Egr-1 protein is induced rapidly in
cells such as SIRC and VERO upon infection. Using
inhibitors of the transcription factors CREB and NFB,
we further investigate the mechanism by which HSV-1
induces Egr-1 activation
Methods
Cells, viruses and culture conditions
VERO (derived from kidney epithelial cells of the Afri-
can Green Monkey) cells and HEK293 cells were grown
in DMEM supplemented with 10% FBS. SIRC (Rabbit
cornea) cells obtained from ATCC (Cat#: CCL-60) were
g r o w ni nM E Ms u p p l e m e n t e dw i t h1 0 %F B S .T h eR E -
EGFP strain of HSV-1 was used throughout the study
[18]. Unless otherwise indicated, all viral infections were
carried with a MOI of 5 for 1 hour.
Western Blot analysis
Protein extract was subjected to 10% sodium dodecyl
sulfate polyacrylamide gel electrophoresis and trans-
ferred onto nitrocellulose membranes. The blots were
blocked using PBS with 5% (wt/vol) non-fat dry milk
and washed in PBS. Rabbit anti-Egr-1 polyclonal anti-
body (Santa Cruz SC-110x) or cAMP response element
binding (CREB) Ser-133 phosphorylation (Abca-
m#ab32096) was used at a dilution of 1:1,000. Anti-a-
Tubulin mouse antibody (Calbiochem, Cat#: CP06, San
Diego, CA) was added at a dilution of 1:10,000. The
chemiluminiscent signal from the membranes was
detected by Syngene GeneGnome HR Bioimaging sys-
tem (Frederick, MD). The protocol was performed
essentially as described by the manufacturer.
Immunofluoroscence
Approximately 20,000 cells were placed in a multi-cham-
ber slide (Cat# 354104 BD Falcon) with respective media
one day before infection. The cells were pretreated for 3
hours with inhibitors Bay 11-7082 (Calbiochem#196871)
and NBD binding peptide (Calbiochem Cat#: 480025) for
the NFкB inhibition study. After infection cells were
rinsed once with 2 ml PBS for 5 min and fixed with 100%
methanol at -20°C. Slides were incubated with 2% normal
blocking serum followed by incubation with primary
antibody for Egr-1 (Millipore# MAB10073) overnight at
4 ° C .T h es l i d e sw e r et h e ni n c ubated with fluorescent
conjugated secondary antibody (Invitrogen cat# A21424),
at RT for 1 hr. Finally, the slides were mounted with
fluorescent mounting medium containing DAPI. The
expression of enhanced green fluorescent protein
(EGFP), red fluorescence, and DAPI staining were
accessed by an Olympus fluorescence microscope (IX71)
coupled with an Olympus digital camera photo apparatus
(DP71). Imaging analysis was performed by using Olym-
pus DP controller software.
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Total RNA was extracted from the cells using trizol
reagent (Invitrogen). RT-PCR was performed using
S u p e r s c r i p tO n e - S t e pR T - P C R( I n v i t r o g e n )w i t h0 . 5μg
of total RNA and primer set for reaction. Their
sequences are as follows: Egr-1: 5’-AGA CCA GTT
ACC CCA GCC AAA C-3’and 5’-AAA ATG TCA GTG
TTC GGC GTG-3’;E G F P :5 ’-GCA GAA GAA CGG
CAT CAA GGT G-3’ and 5’-TGG GTG CTC AGG
TAG TGG TTG TC-3’. The reverse transcription/PCR
reaction was carried out at 45°C for 20 min followed by
25 cycles of 94°C for 30 s, 55°C for 30 s, and 68°C for
30 s. The RT-PCR products were analyzed by 2% agar-
ose gel electrophoresis.
Chromatin Immunoprecipitation (ChIP) assays
Cell monolayers were treated with 1% formaldehyde
solution for 10 min at room temperature. Cells were
then harvested and subjected to sonication. The lysed
samples were centrifuged for 10 min at 13,000 rpm at 4°
C and the supernatant was diluted 10-fold with RIPA
buffer containing protease inhibitor. Immunoprecipita-
tion was then performed with Dynabeads Protein A
(Invitrogen, Cat#: 100.01D) with antibodies against
CREB (Abcam#ab32096) and NFкB (Abcam#ab7970).
To analyze immunoprecipitated DNA, PCR amplifica-
tion was performed with primers against Egr-1 promo-
ter: 5’-TGG GGG GCT TCA CGT CAC TC-3’ and 5’-
AAG TTC TGC GGC TGG ATC TCT C-3’’.T h ep r o -
ducts were analyzed by 2% agarose gel electrophoresis.
Transfection studies involving the dominant negative
mutants of CREB
Approximately 20,000 cells were placed in a multicham-
ber slide (Cat# 354104 BD Falcon) with respective
m e d i ao n ed a yb e f o r et r a n s f e c t i o n .T h ec e l l sw e r e
cotransfected with phMGFP (Promega Cat #E6421) and
one of the vectors (pCMV-CREB133 or pCMV-KCREB)
from the CREB dominant negative vector set (Clonetech
Cat# 631925) using lipofectamine (Invitrogen). fter 2
days, the cells were infected with virus (MOI = 1) for 1
hour. The cells were then incubated in fresh medium
for 24 hours. Immunofluorescence was carried out using
anti-Egr-1 antibody as described above.
Results
Egr-1 protein is induced by HSV-1 infection
T h ee x p r e s s i o no fE g r 1w a se s t a b l i s h e df i r s tu s i n gt h e
VERO cell line as the model for our study because
HSV-1 lytic gene expression is well characterized in
these cells [19-23]. Western blotting analysis showed
that Egr-1 protein was not present in VERO cells but
was induced upon infection and that its induction was
enhanced with increased viral infection (Figure 1A). A
time-course study revealed that detectable levels of
Egr-1 protein were present at 24 hours post infection,
and similar levels were detected at 48 and 72 hours
post infection (Figure 1B). Our data also indicated that
Egr-1 protein was induced in rabbit corneal cells SIRC
under similar conditions (Figure 1C). In addition,
human corneal cell line HCE-2 was sufficient to pro-
duce Egr-1 upon HSV-1 infection (data not shown).
However, Egr-1 was not inducible in HEK293 cells.
Endogenous Egr-1 was present in uninfected 293HEK
cells and the production was not stimulated by viral
infection (Figure 1D). To further confirm the induction
of Egr-1 by HSV-1, immunofluorescence staining was
performed on infected cells. A recombinant HSV-1
constitutively expressing EGFP was used to infect the
cells followed by fixation, blocking, and incubation
with primary and secondary Egr-1 antibody (shown in
red). The results supported the previous observation
that Egr-1 protein (red) was co-expressed only in the
cells infected with EGFP virus (green) (Figure 2).
Together, these results strongly indicated that Egr1
protein was induced by HSV-1 infection.
Egr-1 mRNA was detected at 1 hour post infection
RT-PCR assays were used to analyze Egr-1 mRNA tran-
script expression upon infection. Interestingly, results
showed that Egr-1 mRNA was produced as early as 1
hour post infection and a higher concentration of Egr-1
mRNA was observed 3 hours post infection (Figure 3).
To address whether viral replication was necessary for
Egr-1 production, the same analyses were conducted in
t h ep r e s e n c eo fa c y c l o v i r( A C V ,5 0μM); the results
indicated that viral replication was not required for Egr-
1 mRNA expression (Figure 3). These results demon-
strated that HSV-1 infection increased Egr1 mRNA
transcript expression which occurred immediately after
viral inoculation.
NFкB and pCREB were recruited to the Egr1 promoter
upon infection
The Egr-1 promoter exhibits several transcription factor
binding sites such as NFкB [24] and CREB [25,26].
NFкB has been shown to interact with Egr-1 promoter
[27,28]. ChIP assays were performed 24 hours post
infection to examine the recruitment of NFкBa n d
pCREB to the Egr1 promoter by HSV-1 infection. The
results indicated that NFкB and pCREB were recruited
to the Egr-1 promoter upon infection in SIRC cells
(compare Figure 4A, lanes 1 and 2). This type of recruit-
ment was not seen in HEK293 cells, which exhibited no
Egr1 induction upon infection (compare Figure 4A,
lanes 3 and 4). Additional infection experiments showed
increase in pCREB protein level during HSV-1 infection
(Figure 4B, lane 2). These observations suggested that
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mediated Egr1 expression.
Dominant-negative CREB decreased the Egr-1 induction
observed upon infection
Immunofluorescent analyses were performed to investi-
gate if CREB participated in Egr1 induction. Following
transfection with two dominant negative isoforms of
CREB, pCREB 133 or pKCREB, the number of green
fluorescent cells observed was similar after 2 days, indi-
cating that transfection efficiency was equivalent (Figure
5A). Additional data showed that the use of dominant
negative CREB inhibited the induction of Egr-1 (Figure
5C and 5D) when compared to the GFP control (Figure
5B). Plasmid pCMV-CREB133 encodes a mutated form
of CREB, blocking cAMP-induced transcription, and
preventing CREB phosphorylation at S133. Plasmid
pCMV-KCREB also encodes a mutated form of CREB,
blocking cAMP-induced transcription. These results
indicated that CREB was involved in the virus-mediated
Egr1 expression.
NFкB inhibition reduced Egr-1 expression by infection
The NFкB inhibitor Bay11-7082 (Calbiochem, San
Diego, CA) specifically targets the TNF-a-inducible
phosphorylation of IBa, irreversibly inhibiting and
decreasing expression of NFB [29]. NBD binding pep-
tide is a cell-permeable fusion peptide that inhibits cyto-
kine-induced NF-B activation and NF-B-dependent
gene expression [30]. Immunofluorescence studies
showed that Bay 11-7082 (Figure 6B), and NBD binding
peptide (Figure 6C) have a significant inhibitory effect
A B
C D
1        2
1           2           3          4
Figure 1 Egr-1 protein was induced by HSV-1 infection 24 hours post treatment. a.) This figure is a western blot analysis showing the
expression of Egr-1 protein (83 Kda) in infected VERO cells 24 hours post treatment. MOI of 1, 5, and 10 were used and more viruses led to
more Egr-1 production. Noted that infection at higher moi (Lane 3) led to cell death therefore no significant increase of Egr-1 production was
observed. b.) Egr-1 was induced by HSV-1 infection (MOI-5) in VERO cells and detectable levels were observed at 24, 48, and 72 hours post
treatment. c.) Egr-1 induction was also seen in SIRC cells infected with a MOI of 5. d.) Uninfected HEK 293 cells express Egr1 (lane 1), and no
induction was seen upon infection with HSV-1 MOI 10 (lane 2). Overexpression of Egr-1 was seen in HEK293 cells transfected with Egr1
expression vector (lane 3).
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6A). These results demonstrated that NFB participated
in the induction of Egr1 upon infection.
Discussion
Egr-1 is involved in the gene expression and the replica-
tion of several viruses such as Epstein Barr virus [31,32],
HSV-1 [17,33,34], JC virus [35], orthopox virus [36],
murine corona virus [37], rabies virus [38,39], borna dis-
ease virus [39], human foamy virus [40], Japanese ence-
phalitis virus [38], HTLV-I [41,42] and HTLV-II [42]. In
most cases, Egr-1 was induced after the virus targeted
neural cells and lymphocytes. Our results have demon-
strated an induction of Egr-1 protein upon HSV-1 infec-
tion in epithelial cells such as VERO and SIRC (a
corneal cell line). This observation suggests that Egr-1
EGFP Egr-1
Merge  Merge + DAPI 
EGFP Egr-1
Merge + DAPI  Merge 
No Infection Infection
Figure 2 Immunofluorescence microscopy indicates expression of Egr-1 in HSV-1 infected cells. Immunofluorescence data indicated that
Egr-1(red) is expressed only in the cells infected with HSV-1 EGFP virus (green). Infection controls showed no EGFP signal or Egr-1, indicating the
specificity of the antibody.
Figure 3 Egr-1 mRNA was detected at 1 hour post treatment.
VERO cells were infected with HSV-1 BE EGFP virus or with UV-
inactivated virus at a MOI of 5. Total mRNA was isolated at 1, 2,3,12,
and 24 hours post treatment and RT-PCR was performed.
A
B
1         2          3         4
Figure 4 NFкB and CREB were recruited to the Egr-1 promoter
upon infection. a.) Chip assay was performed using antibodies
against NFкB and CREB. Lane1: Noninfected SIRC cells. Lane 2: SIRC
cells infected with HSV-1 at a MOI of 5. Lane 3: HEK293 cells
infected with virus at a MOI of 5. PCR was performed using primers
for the Egr-1 promoter. For comparison, input controls (lanes 1-3)
indicated the PCR products from samples prior to
immunoprecipitation. b.) Over-expression of CREB protein (37 kda)
was seen in VERO cells infected with HSV-1 (lane 2) when
compared to the mock-infected control (lane 1).
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lytic infection.
Several pathways are known to regulate the induction
of Egr-1 including p38/MAPK [43], JNK [44], MEK/ERK
[45], CREB pathway [46], and NFкB activation [27,28].
By inhibiting the pathways known to be involved in
Egr1 induction, we determined that NFкBa n dC R E B
play roles in Egr1 expression induced by HSV-1. CREB
is activated and stabilized by HSV-1 ICP10 and can
modulate viral-induced apoptosis [47]. Studies have
reported the presence of NFкB regulatory sequence [24]
and CRE [25] in the human Egr-1 promoter. Transient
activation of NFкB during the first few minutes of HSV-
1 infection has been reported [48,49]. In addition, most
of the up-regulated mRNA upon infection was NFкB-
dependent [50]. Furthermore, NFкB-dependent gene
expression is directly related to a number of stress-
induced activities in eukaryotic cells [51]. Since Egr-1 is
induced by stress and is known to control a variety of
divergent cellular responses, it is possible that this
induction is NFкB-dependent. Therefore from the host
cell standpoint, viral infection can be considered as a
stress and Egr1 is rapidly induced to turn on various
cellular responses.
Our previous study showed that Egr1 can bind to the
Egr1 binding element (EBE) located in the intron of
ICP22 and thus regulate the activity of both ICP22 and
ICP4 [17]. Since Egr1 is expressed in neural tissues, it
could play a role in the maintenance of latency and sub-
sequent reactivation. In addition, our preliminary studies
revealed that Egr1 induced by viral infection was suffi-
cient to interact with the ICP22 EBE during the lytic
infection of SIRC and the over-expression of Egr-1
enhanced HSV-1 gene expression, replication, and
release of infectious viruses (unpublished data).
Together, these results suggest the involvement of Egr-1
in HSV-1 gene expression/replication via regulation of
a-genes. Recombinant virus over-expressing Egr-1 and
stable cell lines containing siRNA repressing Egr-1 are
being constructed to further investigate the roles of Egr-
1 during HSV-1 lytic infections.
It is not known which viral proteins are required for
Egr-1 induction. It is likely that the binding of the
viruses to the cell surface is sufficient to trigger the

ŽŶƚƌŽů  ƉZϭϯϯ Ɖ<Z
Figure 5 Dominant negative CREB inhibited the induction of Egr-1 upon HSV-1 infection. VERO cells were transfected with phMGFP alone
and in combination with CREB dominant negative vectors pCREB133 or pKCREB. a.) The transfection efficiency of the three groups is similar as
shown by the number of GFP-positive cells. b.) Cells infected with a control vector show induction of Egr-1 protein (red) whereas cells infected
with the dominant negative mutants, CREB133(c) or KCREB (d) do not show the induction of the Egr-1 protein.
Bedadala et al. Virology Journal 2011, 8:262
http://www.virologyj.com/content/8/1/262
Page 6 of 9expression of Egr-1. Viral binding to the target cell is
mediated by envelope glycoprotein gB, gC, or gD and
the entry is mediated by gD to one of the cell surface
receptors, such as the Herpes Virus Entry Mediator
(HVEM)), heparan sulfate, nectin-1/2, and cell adhesion
molecules from the immunoglobulin superfamily [52].
HVEM belongs to the superfamily of TNF (tumor
necrosis factor)/NGF (nerve growth factor) receptors
A
C
B
Bay 11-7082
NBD binding peptide 
Control 
Figure 6 NFкB inhibitors abolished the induction of Egr-1 upon infection. Egr-1 expression was not induced in cells pretreated with 1 μM
of BAY 11-7082 (b) or 10 μM NBD binding peptide (c) after infection with HSV-1 compared the control (a)
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(TNF receptor like-2) [54]. The Egr-1 gene can be regu-
lated by TNF [55] and NGF [56] in cultured cells, and
NFкB can be activated by the gD/HVEM [57]. There-
fore, Egr-1 induction quite possibly can be correlated to
the binding of viral glycoprotein to HVEM or other cel-
lular surface receptors. Additional experiments are
required to determine the induction mechanisms of Egr-
1 by viral infection.
Conclusion
In summary, we have shown for the first time that Egr1
c a nb ei n d u c e dr a p i d l yb yH S V - 1l y t i ci n f e c t i o ni n
epithelial cells such as VERO and SIRC. This induction
may be due to transactivation by the NFкBa n d / o r
CREB-mediated signaling cascades. The Egr1 induced by
HSV-1 in corneal cells could have implications in viral
pathogenesis, inflammation, and disease progression.
More experiments to determine the role of Egr-1 are
underway, especially in other models of infection.
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